Filing Flows › QuidelOrtho (QDEL) › Recalls, complaints & regulation

QuidelOrtho (QDEL): recalls

QuidelOrtho (QDEL) beyond its filings: 0 recalls in the last 12 months (2 in five years, 0 Class I).

Latest recalls

2024-05-22 · FDA device · VITROS Immunodiagnostic Products Free T3 Calibrators-IVD are for use with Free T3 Reagent Pack for the quantitative measurement of free triiodothyronine (FT3) i
2024-05-22 · FDA device · VITROS Immunodiagnostic Products Free T3 Reagent Pack-IVD is for the quantitative measurement of free triiodothyronine (FT3) in human serum and plasma (EDTA or

QuidelOrtho's latest quarter

QuidelOrtho, Q3 2026: revenue $619M (-12% year over year), operating margin -1.2%, net loss $53.8M, operating cash flow $19.6M. The chart follows the revenue to costs, profit and cash.

Questions

Has QuidelOrtho had any recalls?

2 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.